Risks of online direct-to-consumer tumor markers for cancer screening

Journal of Clinical Oncology

Volumn 30, Issue 13, 2012, Pages 1411-1414

  Lovett, Kimberly M ^a   Liang, Bryan A ^a   Mackey, Timothy K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ALPHA FETOPROTEIN; BETA 2 MICROGLOBULIN; CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 27-29 ANTIGEN; CA 72 4 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CONSUMER; COST; DIRECT TO CONSUMER; FEAR; HEALTH CARE; HUMAN; LABORATORY TEST; MARKETING; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; ACCESS TO INFORMATION; ADVERTIZING; ATTITUDE TO HEALTH; EARLY DIAGNOSIS; ECONOMICS; FINANCIAL MANAGEMENT; FRAUD; HEALTH CARE COST; INTERNET; MASS SCREENING; METHODOLOGY; NEOPLASM; PATIENT EDUCATION; PATIENT SAFETY; PREDICTIVE VALUE; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ACCESS TO INFORMATION; ADVERTISING AS TOPIC; EARLY DETECTION OF CANCER; FRAUD; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNET; MARKETING OF HEALTH SERVICES; MASS SCREENING; NEOPLASMS; PATIENT EDUCATION AS TOPIC; PATIENT SAFETY; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862995407     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.8984     Document Type: Note

References (23)

1. Hesse BW, Nelson DW, Kreps GL, et al: Trust and sources of health information: The impact of the Internet and its implications for health care providers - Findings from the first Health Information National Trends Survey. Arch Intern Med 165:2618-2624, 2005 (Pubitemid 41785059)
2. Lovett K, Liang BA: Direct-to-consumer cardiac screening and suspect risk evaluation. JAMA 305:2567-2568, 2011
3. Liang BA, Mackey T: Direct to consumer advertising with interactive Internet media: Global regulation and public health issues. JAMA 305:824-825, 2011
4. Illes J, Kann D, Karetsky K, et al: Advertising, patient decision making, and self-referral for computed tomographic and magnetic resonance imaging. Arch Intern Med 164:2415-2419, 2004 (Pubitemid 39628067)
5. Cancersafe. http://www.cancersafe.com/concerned/index.asp
6. US Food and Drug Administration: The new 510(k) paradigm: Alternate approaches to demonstrating substantial equivalence in premarket notifications - Final guidance. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm080187.htm
7. US Preventive Services Task Force: Topic index. http://www. uspreventiveservicestaskforce.org/uspstopics.htm
8. National Guideline Clearinghouse: American Society of Clinical Oncology. http://www.guideline.gov/browse/by-organization.aspx?orgid=667
9. Diamandis EP, Sturgeon C, Hoffman B (eds): National Academy of Clinical Biochemistry practice guidelines. http://www.aacc.org/EXPIRED/TumorMarkers/ Pages/TumorMarkersPDF.aspx
10. Lilja H, Semjonow A, Sibley P, et al: National Academy of Clinical Biochemistry guidelines for the use of tumor markers in prostate cancer. http://www.aacc.org/EXPIRED/TumorMarkers/Pages/TumorMarkersPDF.aspx (section 3B)
11. Stieber P, Hatz R, Holdenrieder S, et al: National Academy of Clinical Biochemistry guidelines for the use of tumor markers in lung cancer. http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/tumor/chp3p-lung.pdf (section 3P)
12. Ezzat S, Asa SL, Taupenot L, et al: National Academy of Clinical Biochemistry guidelines for the use of tumor markers in neoplasms of the dispersed neuroendocrine system. http://www.aacc.org/SiteCollectionDocuments/ NACB/LMPG/tumor/chp3n-neuroendocrine.pdf (section 3N)
13. Brünner N, Haglund C, Holten-Andersen M, et al: National Academy of Clinical Biochemistry guidelines for the use of tumor markers in colorectal cancer. http://www.aacc.org/SiteCollectionDocuments/NACB/LMPG/tumor/chp3c- colorectal.pdf (section 3C)
14. Health Testing Centers: Blood test price list. http://www. healthtestingcenters.com/blood-test-prices.aspx
15. Direct Labs: Cancer. https://www.directlabs.com/Default.aspx?&catid= 81&language=en-US&tabid=55
16. Allen M: Illinois sues Heart Check America over body scan sales. Chicago Tribune, June 23, 2011. http://articles.chicagotribune.com/2011-06-23/health/ chi-lawsuit-accuses-heart-check-america-of-deceptive-practices-20110623-1- multiple-scans-electron-beam-tomography-heart-disease
17. World Health Organization: Cancer: Key facts. http://www.who.int/ mediacentre/factsheets/fs297/en/index.html
18. US Food and Drug Administration: FDA oversight of direct-to-consumer advertising of medical devices: Statement of David Schultz before Senate Special Committee on Aging. http://www.fda.gov/NewsEvents/Testimony/ucm096272.htm
19. US Food and Drug Administration: Inspections, compliance, enforcement, and criminal investigations: Regulatory procedures manual. http://www.fda.gov/ ICECI/ComplianceManuals/RegulatoryProceduresManual/ucm176980.htm
20. Federal Trade Commission Act, 15 U.S.C. § 41 et seq
21. California Unfair Competition Law, Cal. Bus. & Prof. Code §§ 17200-17209
22. USDepartment of Health and Human Services: Summary from the Molecular and Clinical Genetics Panel Meeting: March 8-9, 2011. http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteeMeetingMaterials/MedicalDevices/ MedicalDevicesAdvisoryCommittee/MolecularandClinicalGeneticsPanel/UCM246907.pdf
23. World Health Organization: The 3 by 5 initiative: HIV testing and counseling - The gateway to treatment, care and support. http://www.who.int/ 3by5/publications/briefs/hiv-testing-counselling/en/index.html